HOCPF
Price
$126.95
Change
-$7.36 (-5.48%)
Updated
Aug 26 closing price
Capitalization
47.39B
IRME
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
1.35M
86 days until earnings call
Interact to see
Advertisement

HOCPF vs IRME

Header iconHOCPF vs IRME Comparison
Open Charts HOCPF vs IRMEBanner chart's image
Hoya
Price$126.95
Change-$7.36 (-5.48%)
Volume$623
Capitalization47.39B
IR-Med
Price$0.02
Change-$0.00 (-0.00%)
Volume$2.95K
Capitalization1.35M
HOCPF vs IRME Comparison Chart in %
Loading...
HOCPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOCPF vs. IRME commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOCPF is a Hold and IRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (HOCPF: $126.95 vs. IRME: $0.02)
Brand notoriety: HOCPF and IRME are both not notable
HOCPF represents the Pharmaceuticals: Other, while IRME is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HOCPF: 51% vs. IRME: 2%
Market capitalization -- HOCPF: $47.39B vs. IRME: $1.35M
HOCPF [@Pharmaceuticals: Other] is valued at $47.39B. IRME’s [@Medical/Nursing Services] market capitalization is $1.35M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOCPF’s FA Score shows that 0 FA rating(s) are green whileIRME’s FA Score has 0 green FA rating(s).

  • HOCPF’s FA Score: 0 green, 5 red.
  • IRME’s FA Score: 0 green, 5 red.
According to our system of comparison, both HOCPF and IRME are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOCPF’s TA Score shows that 5 TA indicator(s) are bullish while IRME’s TA Score has 2 bullish TA indicator(s).

  • HOCPF’s TA Score: 5 bullish, 3 bearish.
  • IRME’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, HOCPF is a better buy in the short-term than IRME.

Price Growth

HOCPF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while IRME (@Medical/Nursing Services) price change was +8.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

Reported Earning Dates

IRME is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOCPF($47.4B) has a higher market cap than IRME($1.35M). HOCPF YTD gains are higher at: 3.974 vs. IRME (-96.479). HOCPF has higher annual earnings (EBITDA): 310B vs. IRME (-1.45M). HOCPF has more cash in the bank: 539B vs. IRME (63K). IRME has less debt than HOCPF: IRME (250K) vs HOCPF (37.3B). HOCPF has higher revenues than IRME: HOCPF (886B) vs IRME (0).
HOCPFIRMEHOCPF / IRME
Capitalization47.4B1.35M3,503,326%
EBITDA310B-1.45M-21,394,065%
Gain YTD3.974-96.479-4%
P/E Ratio32.32N/A-
Revenue886B0-
Total Cash539B63K855,555,556%
Total Debt37.3B250K14,920,000%
FUNDAMENTALS RATINGS
HOCPF vs IRME: Fundamental Ratings
HOCPF
IRME
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5366
P/E GROWTH RATING
1..100
71100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOCPF's Valuation (77) in the null industry is in the same range as IRME (96). This means that HOCPF’s stock grew similarly to IRME’s over the last 12 months.

HOCPF's Profit vs Risk Rating (77) in the null industry is in the same range as IRME (100). This means that HOCPF’s stock grew similarly to IRME’s over the last 12 months.

HOCPF's SMR Rating (99) in the null industry is in the same range as IRME (100). This means that HOCPF’s stock grew similarly to IRME’s over the last 12 months.

HOCPF's Price Growth Rating (53) in the null industry is in the same range as IRME (66). This means that HOCPF’s stock grew similarly to IRME’s over the last 12 months.

HOCPF's P/E Growth Rating (71) in the null industry is in the same range as IRME (100). This means that HOCPF’s stock grew similarly to IRME’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOCPFIRME
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
47%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
60%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
61%
Bullish Trend 4 days ago
55%
MACD
ODDS (%)
Bearish Trend 4 days ago
61%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
52%
Bullish Trend 4 days ago
48%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
46%
Bullish Trend 4 days ago
39%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
59%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
HOCPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARM0.400.08
+25.59%
Carisma Therapeutics
AMN20.850.62
+3.06%
AMN Healthcare Services
NUE147.262.32
+1.60%
Nucor Corp
COTY4.37-0.01
-0.23%
COTY
SMHI6.45-0.03
-0.46%
SEACOR Marine Holdings

HOCPF and

Correlation & Price change

A.I.dvisor tells us that HOCPF and HOCPY have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HOCPF and HOCPY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOCPF
1D Price
Change %
HOCPF100%
N/A
HOCPY - HOCPF
25%
Poorly correlated
+3.59%
FZMD - HOCPF
11%
Poorly correlated
N/A
IDTA - HOCPF
5%
Poorly correlated
N/A
IRME - HOCPF
1%
Poorly correlated
+8.68%
GNNDY - HOCPF
0%
Poorly correlated
+4.10%
More

IRME and

Correlation & Price change

A.I.dvisor tells us that IRME and CZMWY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRME and CZMWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRME
1D Price
Change %
IRME100%
+8.68%
CZMWY - IRME
28%
Poorly correlated
-0.47%
XAIR - IRME
27%
Poorly correlated
+1.84%
SRTOY - IRME
24%
Poorly correlated
N/A
CZMWF - IRME
21%
Poorly correlated
N/A
GNGBY - IRME
11%
Poorly correlated
+1.18%
More